Home/Tychon Bioscience/Carston Rick Wagner, Ph.D.
CR

Carston Rick Wagner, Ph.D.

Chief Scientific Officer

Tychon Bioscience

Therapeutic Areas

Tychon Bioscience Pipeline

DrugIndicationPhase
TYC201 (Anti-EpCAM PARs)Solid Tumors (Breast/Colon)Pre-clinical
Anti-CD133 PARsCancer Stem CellsDiscovery
Anti-CD19 PARsLeukemia/LymphomaDiscovery
Universal CAR T-cell Hybrid CAR/PARNot SpecifiedDiscovery